Yeh YC, Lin HH, Tang MJ. A tale of two collagen receptors, integrin ␤1 and discoidin domain receptor 1, in epithelial cell differentiation. Am J Physiol Cell Physiol 303: C1207-C1217, 2012. First published September 26, 2012; doi:10.1152/ajpcell.00253.2012.-As increase in collagen deposition is no longer taken as simply a consequence but, rather, an inducer of disease progression; therefore, the understanding of collagen signal transduction is fundamentally important. Cells contain at least two types of collagen receptors: integrins and discoidin domain receptors (DDRs). The integrin heterodimers ␣ 1␤1, ␣2␤1, ␣10␤1, and ␣ 11␤1 are recognized as the non-tyrosine kinase collagen receptors. DDR1 and 2, the tyrosine kinase receptors of collagen, are specifically expressed in epithelium and mesenchyme, respectively. While integrin ␤ 1 and DDR1 are both required for cell adhesion on collagen, their roles in epithelial cell differentiation during development and disease progression seem to counteract each other, with integrin ␤ 1 favoring epithelium mesenchyme transition (EMT) and DDR1 inducing epithelial cell differentiation. The in vitro evidence shows that the integrin ␤ 1 and DDR1 exert opposing actions in regulation of membrane stability of E-cadherin, which itself is a critical regulator of epithelial cell differentiation. Here, we review the functional roles of integrin ␤ 1 and DDR1 in regulation of epithelial cell differentiation during development and disease progression, and explore the underlining mechanisms regarding to the regulation of membrane stability of E-cadherin. collagen; integrin ␤1; DDR1; epithelial cell differentiation; EMT; fibrosis; development
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THE BIOLOGICAL FUNCTIONS OF COLLAGEN
Collagen, the most abundant protein in the human body, constitutes the major component of basement membrane and connective tissues, such as tendon, cartilage, bone, skin, cornea, and blood vessels. Collagens are composed of triplehelices of ␣ chain with the repeating sequence Gly-X-Y. The X and Y could be any kind of amino acid, but proline and hydroxyproline are the most commonly used. The cross-links between triple-helices of collagen fibers determine whether their tertiary structure is bundles, sheets, or filaments. The difference depends on the composition of ␣ chain subunits. While 42 genes encoding ␣ chains have been identified in the human genome, only 27 types of collagens have been revealed. Some collagens contain three identical ␣ chains, and others contain two or three different types of ␣ chains. According to their organization and functional properties, collagens are divided into distinct groups. Type I, II, and III collagens are the major types of fibrillar collagen forming tenacious structures including tendon and cartilage where they provide tensile strength to resist the higher force exerted on tissues. The posttranslational modification and calcification of type I collagen are accompanied by bone morphogenesis and result in the stiffest structure in our bodies. Type IX and XII collagens, the fibril-associated collagens, function as linkers between collagen bundles or within collagens and other macromolecules. Type IV collagen, the most essential protein in basement membrane, forms meshlike structures providing cross-links with other components of extracellular matrix (ECM). Collagen type XVII, a transmembrane non-fibrillar collagen, is a component of hemidesmosome formation. Collagen type XVIII, another non-fibrillar collagen, is the core protein of proteoglycan.
Mutations in collagen that lead to abnormal arrangements result in rare genetic diseases, such as fragile skin, cartilage deficiency, or severe bone defects. In addition to genetic mutations, abnormal expression of fibrillar collagen is frequently observed with progression of diseases including carcinogenesis and organ fibrosis (21, 32) . The excessive accumulation of fibrillar collagens can progress to organ failure and lead to death. Epithelial cells are the functional units for many organs, including skin, lung, liver, GI tract, kidney, and mammary gland. Therefore, an understanding of the biological functions of collagen in epithelial cells is important to dissecting pathophysiological mechanisms and providing new insights useful to design therapeutic strategies.
Under physiological conditions, epithelial cells reside on the basement membrane sheet, which forms a natural barrier to the underlying fibrillar collagen. However, during tissue fibrosis or cancer progression, the integrity of the basement membrane is interrupted because of remodeling by active fibroblasts or transformed epithelial cells. This causes epithelial cells to be exposed to the underlying fibrillar collagen. In addition, stimulation by cytokines and/or growth factors may increase the abundance of membrane receptors for fibrillar collagen that can influence cell behavior. In vitro studies show that fibrillar collagen can trigger the loss of epithelial plasticity, including cell polarity, aggregation, and junctional formation, while triggering the gain of mesenchymal properties, including cell migration, invasion, extensive phenotypic changes, and ECM deposition (24, 87) . All of these changes illustrate the negative consequences of fibrillar collagen in regulation of epithelial cell differentiation.
Two types of collagen receptors have been described in vertebrates: integrins and discoidin domain receptors (DDRs). The functions of integrin family members in epithelial cells have been intensively studied. However, studies of DDR family members in epithelial cells are relatively few and indicate counteractive functions of DDRs to integrin actions, particularly in epithelial cell differentiation. Here we will focus on the structures, functions, and the downstream signals of both collagen receptors in regulating epithelial cell differentiation.
INTEGRIN ␤1

The Physiological Functions of Integrin ␤ 1 : Development and Tissue Organization
Cell adhesion provides the "permission" signal for most cells to undergo cell differentiation. Integrin ␤ 1 is the major adhesion receptor for various ECM components. Its functions in epithelial differentiation have been studied by conditional gene deletion in mice. Not surprisingly, the loss of integrin ␤ 1 usually leads to pathologies in cell differentiation. In the intestinal epithelium, for example, conditional deletion of integrin ␤ 1 increases epithelial cell proliferation and leads to dysplasia and polypoid structures. This intestinal hyperplasia overtakes differentiation and leads to severe malnutrition and early postnatal lethality (45) .
In mouse, perturbation of integrin ␤ 1 functions impairs development of mammary gland and differentiation of secretory epithelium (26) . Integrin ␤ 1 deletion also leads to impaired mammary gland epithelial integrity and loss of polarity. The polarized distribution of laminin, integrin ␤ 4 , and the tight junction component protein, ZO-1, were lost in integrin ␤ 1 -null luminal epithelial cells (61) . This result suggests that the signal from integrin ␤ 1 provides not only cell-ECM adhesion cues but also polarization cues. In addition to the regulation of normal epithelial differentiation, studies have exposed the essential role of integrin ␤ 1 in the maintenance of the functional stem cell population and in the segregation of two major mammary cell lineages. Loss of integrin ␤ 1 impaired cell axis differentiation during cell division in the mammary gland basal cells. Therefore, the homeostasis between functional stem cell and epithelial cell populations was disrupted, which affected mammary gland morphogenesis and the regenerative potential of mammary epithelium (69) .
Differential expression of integrin family members has been thoroughly examined during lung development (19) . In the early pseudoglandular stage, integrins ␣ 2 , ␣ 5 , ␣ 6 , ␣ v , and ␤ 1 are all detectable in the epithelial plasma membrane of distal airways and in myoepithelial cells. At the same stage, the polarized but undifferentiated tracheal epithelial cells express integrins ␣ 3 , ␣ 6 , and ␤ 1 in the basal-lateral membrane. Once tracheal epithelia finish differentiating, only integrins ␣ 6 and ␤ 4 are expressed. On the other hand, the secretory cells in the submucosal glands express integrins ␣ 2 , ␣ 3 , ␣ 4 , ␣ 6 , and ␤ 1 (19) . These results suggest that integrin expression patterns are responsible for addressing specific demands in the maturation of respiratory epithelium and glands during organogenesis.
Mice with podocyte-specific deletion of integrin ␤ 1 are born normally but do not complete postnatal renal development. They exhibit detectable proteinuria on day 1 and die within a week. The kidneys exhibit normal glomerular endothelium but show severe glomerular basement membrane defects with multilaminations and splitting including podocyte foot process effacement. Loss of integrin-linked kinase (ILK) in the podocytes provokes postnatal proteinuria at birth, and mice die within 15 wk of age due to renal failure. These results indicate that podocyte integrin ␤ 1 and ILK signaling are critical for postnatal development and function of the glomerular filtration apparatus (47) .
Integrin ␤ 1 is required for ureteric bud branching morphogenesis, collecting duct morphogenesis, and maintenance of renal function (80, 88) . The branching morphogenesis of ureteric bud requires signaling by growth factors such as glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factors (FGFs) as well as cell extracellular interactions mediated by integrins. Zhang et al. (88) found that canonical signaling pathways activated by FGFs were decreased in ␤ 1 integrin-null ureteric buds in vivo, despite the normal activation state of the FGF receptor (88) . Mice with integrin ␤ 1 deletion in the kidney collecting system exhibited a range of defects from small kidneys with cysts and dilated tubules to bilateral renal agenesis. Histological examination of these mutant mice showed the hypoplastic renal medullary collecting ducts, characterized by increased apoptosis, ectasia, and cyst formation. The defect in the concentrating ability of the kidney was concomitant with decreased expression of aquaporin-2 and arginine vasopressin receptor 2 in the medullary-collecting duct. This was likely due to altered growth and branching morphogenesis of the ureteric bud, despite the apparent ability of the ureteric bud-derived cells to induce differentiation of the metanephric mesenchyme (80) .
In normal epidermis, the expression of integrin ␤ 1 is restricted in the basal-lateral side of the basal layer. Its functions are crucial to maintain keratinocyte adhesion, proliferation, and migration (35) . Ectopic suprabasal expression of integrin ␤ 1 leads to hyperproliferation and morphological changes resembling human psoriasis (18) , whereas the conditional ablation of integrin ␤ 1 leads to severe skin blistering due to near complete loss of the basement membrane, reduction in hemidesmosomes, severely reduced proliferative compartment in the epidermis, and defects in hair follicle morphogenesis (12, 63) . Although epidermal proliferation is impaired, a spatial and temporal program of terminal differentiation is maintained (63) , which seems to conflict the in vitro studies. Studies with the human keratinocytes showed that the suspended-induced terminal differentiation in in vitro culture was associated with decreased expression of mature integrin ␤ 1 on cell surface (1, 42, 43) , and engagement of integrin ␤ 1 with antibody suppressed terminal differentiation (42) . The conflicting results in in vivo and in vitro studies indicate that there exists a more complicate regulatory mechanism in keratinocyte differentiation in vivo and that cell-cell contact could be an important issue.
The Pathological Functions of Integrin ␤ 1 : Fibrosis and Cancer
Fibrosis. Chronic inflammation, fibroblast activation, and epithelial-to-mesenchymal transition (EMT) are the three major contributors to organ fibrosis. Although controversy has been raised on the role of EMT during organ fibrosis, sustained expression of transforming growth factor ␤1-1 (TGF-␤1) triggered by chronic inflammatory response promotes the activation of fibroblasts cells has been established. Likewise, TGF-␤1 may also trigger transdifferentiation of epithelial cells. Both the activation of fibroblasts and EMT contribute to the expansion of the myofibroblast population, which shows higher contractile force, migratory ability, ECM deposition, and remodeling capacity. Expansion of myofibroblasts, therefore, is considered as a major cause and diagnosis marker for organ fibrosis (46, 72) .
Kim and colleagues (49, 50) demonstrated that the alveolar epithelial cells undergo EMT in response to TGF-␤1 treatment in both in vivo and ex vivo experimental fibrosis models. Suppressing integrin ␣ 3 ␤ 1 reduced the progression of idiopathic-induced pulmonary fibrosis as assessed by the accumulation of myofibroblasts and the deposition of type I collagen. They further found that integrin ␣ 3 ␤ 1 forms a complex with the TGF-␤1 receptor and E-cadherin in the apical junction. Upon TGF-␤1 stimulation, integrin ␣ 3 ␤ 1 triggered pY654-␤-catenin/ pSmad2 complex formation and turned on EMT-relative gene expression downstream (49, 50, 51) .
During renal fibrosis, the percentage of myofibroblasts derived by EMT is 36%, which is higher than the 10% contribution of myofibroblasts in pulmonary fibrosis (46, 52) . We found that TGF-␤1 induced an augmentation of ␤ 1 integrin expression within 4 h, before the downregulation of E-cadherin and the upregulation of ␣-smooth muscle actin (␣-SMA) and fibronectin seen at 24 h in kidney epithelial cells (85) . Blocking integrin ␤ 1 inhibited TGF-␤1-induced EMT, while ectopic expression of the active form of integrin ␤ 1 triggered EMT. In an in vivo mouse model established by unilateral ureteral obstruction (UUO)-induced renal chronic tubulointerstitial fibrosis we also found that upregulation of integrin ␤ 1 appeared before the initiation of EMT. More importantly, blocking integrin ␤ 1 signaling suppressed the progression of fibrosis (85) . The downstream protein kinase of integrin ␤ 1 , namely ILK, plays a similar role in mediating renal tubular EMT and interstitial fibrosis (57, 58) . Taken together, the findings suggest that the signaling mediated by integrin ␤ 1 /ILK might play an important role in the progression of chronic tubulointerstitial fibrosis and identify a potential therapeutic target for the prevention of renal fibrosis (Fig. 1) .
Cancer. When cancer cells become metastatic, they develop altered avidity and affinity for the ECM. This phenotypic change is partly due to alterations in the expression of integrins. The abnormal expression and activation of integrin ␤ 1 has been studied extensively during cancer progression. In a transgenic mouse model of breast tumorigenesis, integrin ␤ 1 was found to be essential for oncogenic transformation and the maintenance of proliferative capacity in vivo (79) . The integrin ␣ 5 ␤ 1 was upregulated in malignant cells compared with nonmalignant breast cells, and inhibitory antibodies enhanced the growth-inhibitory apoptosis of human breast cancer cell lines in response to ionizing radiation (60) . Animals bearing integrin ␤ 1 -deficient ErbB2 tumors exhibited significantly reduced tumor volume, which was associated with increased tumor cell apoptosis and a reduction in tumor angiogenesis. In addition, integrin ␤ 1 -deficient tumors were compromised in their capac- ity to metastasize to the lung, a deficiency associated with abrogation of adhesion signaling. This evidence suggests that integrin ␤ 1 is dispensable for the initiation of ErbB2 tumor induction but plays a critical role in the metastatic phase of tumor progression (40) . The expression of integrins has been suggested to play a role in predicting the clinical course and prognosis of non-small cell lung carcinoma (NSCLC). Okamura et al. (62) found that increased integrin ␤ 1 expression was a prognostic factor for poor overall survival in NSCLC patients. Dingemans et al. (22) also found that the expression levels of integrins ␣ 5 , ␤ 1 , and ␤ 3 predicted the poor overall survival and disease-free survival in early stage NSCLC patients (22) . Comparison between the histological subtypes revealed a distinct integrin signature for squamous cell carcinoma while the profiles of adenocarcinoma and large cell carcinoma were largely the same. These results suggest that integrin ␤ 1 expression in NSCLC is important for the development and behavior of the tumor and influences the survival of the patient. The development of tumor metastases involves multiple steps, and the integrin ␤ 1 -focal adhesion kinase (FAK) signaling axis has been demonstrated to play an important role in controlling lung metastasis and the initial proliferation of micrometastatic cancer cells disseminated in the lungs (67) .
Renal cell carcinoma is a malignant tumor with a poor prognosis and high metastatic potential. The expression of integrin ␤ 1 was positively correlated with increased metastatic potential of renal tumor cells (73) . Brenner et al. (14) further showed that migration of renal carcinoma cells is dependent on protein kinase C-␦ (PKC␦) via affecting the expression and activation of integrin ␤ 1 and FAK. Thus, the inhibition of PKC␦ is also critical for the suppression of metastases of renal cell carcinoma (14) .
In vulval squamous cell carcinomas, integrin ␤ 1 is overexpressed and in an active conformation compared with normal tissue. In vitro analysis revealed that integral ␤ 1 was required for cell adhesion, cell spreading, and invasion. In vivo study indicated that integrin ␤ 1 knockdown tumors were more encapsulated and less invasive compared with control tumors (15) . The tumor cells undergoing EMT are believed to be more invasive, and expression of integrin ␤ 1 is one of the major inducers in triggering EMT. The encapsulation of integrin ␤ 1 knockdown cancer cell mass supports this notion. Other evidence showed that overexpression of the constitutively active form of integrin ␤ 1 in the squamous cell carcinoma not only contributed to cell spreading, proliferation, and invasive ability, but also increased the cell population with poor differentiation (27) . Multiple studies have shown that the integrin ␤ 1 -mediated Src/FAK signaling axis increased the endocytosis of E-cadherin, which contributed to the integrin ␤ 1 -induced increase in cancer cell invasive ability (6, 7, 17) (Fig. 1 and see discussion below).
DISCOIDIN DOMAIN RECEPTOR 1
The Physiological Functions of DDR1: Development and Tissue Organization DDR1 is widely expressed during embryonic development and in adult tissues, particularly in epithelia of skin, lung, liver, kidney, gut, colon, and brain (9), whereas DDR2 shows higher expression in heart, muscles, and connective tissues (48, 54) .
Studies with recombinant protein composed of the extracellular domain of DDR1 fused to alkaline phosphatase indicated, by immunohistochemistry, high expression of DDR1 and its ligand in the uterus track. In the preimplantation uterus, both the longitudinal muscles and the outer layer of the myometrium expressed high levels of DDR1, whereas it was absent in the glandular epithelium and in the stroma. After implantation, the DDR1 and its ligand were expressed in the decidual cells and the decidual zone around the embryo, respectively. In contrast, the embryo was negatively stained for ligand or receptor (75) . These results suggest that DDR1 plays important roles in the peri-implantational adhesion between luminal epithelium and the blastocyst. This notion has been supported in DDR1-knockout mice, since these female animals are mostly infertile owing to defects in blastocyst implantation.
DDR1-knockout mice survived gestation but are smaller in size than control littermates. These mice showed defects in the development of certain organs, such as impaired mammary gland development, poorly calcified fibula bone, and a narrower pelvis (75) . The DDR2-knockout mice showed dwarfism and shortening of long bones caused by the decrease of chondrocyte proliferation (53) . A recent study showed that mutation of the DDR2 gene in humans led to similar characteristics, such as short limbs, narrowed chest, and chondral calcification (8) ; this rare autosomal-recessive disease was first identified in 1993 and is known as spondylo-meta-epiphyseal dysplasia (SMED). These results suggest that despite the different expression patterns of DDR1 and 2 in epithelial and stoma cells, overlapping expression and function can exist. Since DDR1 is mainly expressed in epithelium, we focused on the functions of DDR1 in epithelial cell differentiation.
In addition to the above defects present in DDR1-knockout mice, mutant females are unable to lactate because of the failure of alveolar epithelium to secrete milk proteins. During pregnancy, DDR1-null female mice showed hyperproliferation and aberrant differentiation of lobulo-alveolar epithelial cells. At birth, the alveoli showed intracellular lipid production and deposition but failure to secrete milk into the central lumen. In the early pubertal stage, the mammary gland development defect was manifest as a delay in mammary duct outgrowth, enlargement in primary ducts, and the terminal end buds due to a marked increase in cell proliferation rate in the mutant mice (75) . In addition, a substantial deposition of collagen was shown in and around mammary gland epithelial cells in DDR1-knockout mice. In view of findings that normal mammary epithelia grow and differentiate on the collagen-enriched ECM, these observations indicate that DDR1 has two important functions, i.e., inhibition of epithelial cell proliferation and regulation of collagen deposition. Both of the functions play important roles in regulation of epithelial cell differentiation.
By conjugating the extracellular domain of DDR1 with human alkaline phosphatase, Vogel et al. (75) demonstrated that the highest DDR1-binding site with the expression of DDR1 was detected in the developing teeth, skin, and vibrissae. In contrast, while DDR1 is expressed in developing and adult mouse brain, particularly in the cortex, hippocampus, and cerebellum (10, 65), there is a low level of DDR1-binding sites in these areas (75) . Since brain development is apparently normal in DDR1-knockout mice, DDR1 may be regulated through the collagen-independent mechanisms during brain development. In contrast, in skeleton, there are ample DDR1-binding sites and DDR1-knockout mice exhibit shorter long bone development compared with heterozygous mice. Further studies demonstrate that DDR1-knockout mice exhibit similar morphology of the growth plates in the tibia and metatarsus and display similar growth rates of chondrocyte, suggesting that the dwarfism induced by DDR1 knockout is not due to the growth defect of bone (75) .
Expression of DDR1 in skin tissue is important for the spatial localization of melanocytes to the basement membrane. Studies showed that the adhesion signal from the basement membrane is required for the survival of melanocytes and that DDR1 knockdown decreased the adhesion of melanocyte to the type IV collagen, one of the major components of basement membrane (31) . Expression of CCN3, a matricellular protein, also plays a critical role in the spatial localization of melanocytes to the basement membrane. And expression of DDR1 is required for CCN3-mediated melanocyte localization. Since integrins, including integrin ␣ 5 ␤ 1 , ␣ 6 ␤ 1 , and ␣ v ␤ 5 , are the main receptors for CCN3, it is possible that integrins would be involved in the regulation of DDR1 expression induced by CCN3, which then controls the epidermal homeostasis and tissue organization.
The DDR1-knockout adult mice exhibit proteinuria and urinary acanthocytes. Results from electron microscopy demonstrate thickening of subepithelial glomerular basement membrane as well as a focal loss of the podocyte slit diaphragms. These data suggest that the loss of cell-matrix communication in DDR1-deficient podocytes appears to result in excess accumulation of basement membrane proteins, which leads to disturbed anchorage of foot processes and disruption of the slit diaphragm. In other words, the interaction between type IV collagen and DDR1 plays an important role in maintaining the structural integrity of the glomerular basement membrane (36) .
The Pathological Functions of DDR1: Fibrosis and Cancer
Fibrosis. DDR1-null mice are protected against bleomycininduced pulmonary fibrosis compared with wild-type mice. Bleomycin-induced collagen deposition, tenascin-C upregulation, myofibroblast expansion and apoptosis were reduced in DDR-knockout mice. Furthermore, also diminished in the DDR1-null mice were the inflammatory responses, as estimated by macrophage and lymphocyte infiltration and upregulation of IL-1 and the macrophage-chemoattractant protein (MCP)-1. These results suggest that the expression of DDR1 in the inflammatory cells is a prerequisite for the development of lung inflammation and fibrosis (4). However, a recent study reported that the expression of DDR1 in the alveolar and bronchial epithelial cells was downregulated during TGF-␤1-induced EMT, which suggests that loss of DDR1 may be associated with TGF-␤1-induced dedifferentiation of alveolar and bronchial epithelial cells (16) .
In experimental hypertension provoked by angiotensin IIinfusion, DDR1-deficient mice showed similar increases in systolic pressure, but less perivascular inflammation, glomerular sclerosis, and proteinuria compared with wild-type mice. In addition, in angiotensin II-infused DDR1-null mice, there was a substantial reduction of lymphocytes and macrophages infiltration with reduced immunostaining for collagens I and IV in the renal cortex (28) . Similarly, DDR1-knockout mice exhibited markedly reduced chronic tubulo-interstitial fibrosis. In the UUO-induced renal fibrosis model, decreased collagen deposition, leucocytes infiltration and cytokines expression were evident (38) . In this study, DDR1 expression was observed in leukocytes and macrophages as well as interstitial cells during inflammation, indicating the importance of the DDR1-mediated inflammation response in the progression of renal fibrosis. The DDR1 deficiency-reduced inflammation and fibrosis has also been reported in Alport syndrome, a hereditary type IV collagen disease leading to progressive renal fibrosis, hearing loss, and ocular changes. In COL4A3 Ϫ/Ϫ -induced Alport syndrome, loss of DDR1 attenuates the accumulation of proinflammatory and profibrotic cells and deposition of ECM induced by TGF-␤, connective tissue growth factor, NF-B, and IL-6 (37). Taken together, DDR1-mediated inflammatory response plays a critical role in the development of renal fibrosis induced by angiotensin II, UUO, and other pathological triggers.
Functions of DDR1 in epithelial cell differentiation have been intensively studied by employing DDR1 overexpression and knockdown in cultured epithelial cells. We have shown that overexpression of DDR1 inhibits, whereas knockdown of DDR1 augments, collagen-induced cell migration (76, 77) , spreading (84), cell-cell dissociation, endocytosis of E-cadherin, and decrease in microvilli formation (86) . Furthermore, our unpublished results show that the expression of DDR1 suppresses TGF-␤1-induced EMT as manifested by an increase in stress fiber formation, fibronectin deposition, downregulation of E-cadherin, and upregulation of ␣-SMA. In contrast, knockdown of DDR1 increased TGF-␤1-induced EMT in kidney and mammary epithelial cells. In addition, we found that DDR1 is markedly decreased in renal epithelial cells in both a UUO-induced renal fibrosis animal model and the human samples of fibrotic kidney (unpublished observations). Taken together, these studies show that the functions of DDR1 in different type of cells, notably, epithelial and inflammatory cells, are very different. DDR1 expression promotes epithelial cell differentiation but facilitates inflammatory response by triggering the adhesion and differentiation of inflammatory cells (Fig. 1A) .
Cancer. Protein kinases are frequently mutated during tumorigenesis. The genomic DNA sequencing for 518 protein kinases in tumor samples from patients with NSCLC showed that DDR1 contained three somatic mutations: A496S, R824W, and G1486T. However, the functional relevance of these mutations to DDR1 function has not been elucidated (20) . A screening of 146 NSCLC tissue samples showed that DDR1 was significantly upregulated, whereas DDR2 was significantly downregulated. The expression of DDR2 was not predictive of patient survival; however, expression of DDR1 was significantly associated with overall and disease-free survival. Multivariate analysis revealed that expression of DDR1 is independent of tumor differentiation, stage, histology, and patient age. A screening for DDR mutations revealed one polymorphism with synonymous change at S495, unlikely to be of functional importance (29) . Another screening of 171 NSCLC samples, encompassing 86 squamous cell carcinomas, 69 adenocarcinomas, and 16 pure bronchioloalveolar carcinomas (BAC), indicated that DDR1 upregulation was more frequent in invasive adenocarcinoma (64%) compared with BAC (38%; 83). In addition, DDR1 expression was significantly correlated with lymph node metastasis in invasive NSCLC. Overexpression of DDR1 in lung cancer cells resulted in a significant increase in cell motility and invasiveness, which may correlate with the induction of matrix metalloproteinase-9 (83). These findings indicate that upregulation of DDR1 may contribute to the progression and poor prognosis of certain types of NSCLC and that this effect may be attributed to increased invasiveness.
Upregulation of DDR1 in breast cancer was described almost 20 years ago (3, 44) . However, unlike NSCLC, expression of DDR1 is negatively correlated with cancer cell invasive ability in breast cancer, because the interaction of DDR1 and dopamine and cAMP-regulated neuronal phosphoprotein (DARPP-32) in cancer cells would negatively regulate cancer cell migration (39) . An assessment of invasive ductal and lobular carcinomas (IDC and ILC) showed that the EMTrelated genes, or genes correlated with TGF-␤ and Wnt signaling, appeared to be more prominent in ILC. On the other hand, immunostaining for several proteins, including E-cadherin, EMP1, DVL1, and DDR1, distinguished large sets of IDC from ILC (74) . Our recent work also showed that expression of DDR1 was restricted to the non-EMT breast cancer cell lines (86) . These results indicate that the expression of DDR1 positively correlates with breast cancer cell differentiation, as estimated by the expression of E-cadherin, but negatively correlates with cell invasive or metastasis ability.
A recent study with A431 squamous cell carcinoma showed that the E-cadherin-dependent expression of DDR1 at cell-cell junctions was required for the recruitment of Par3/Par6 complex and the localization of RhoE at these junctions. Activation of RhoE suppressed ROCK-driven actomyosin contractility and then stabilized cell-cell contacts. Both two-dimensional in vitro cell culture analysis and three-dimensional in vivo invasion assays show that the expression of DDR1 with Par3/Par6 complex is required for the cohesive cancer cell migration (41) . Upregulation of DDR1 was also seen in ovarian cancer with the coexpression of adhesion molecules (40) . These results, taken together, indicate that DDR1 may be expressed in differentiated cancer cells, which still maintain the epithelial adhesion molecules (Fig. 1) .
FUNCTIONS OF INTEGRIN ␤1 AND DDR1 IN EPITHELIAL CELL DIFFERENTIATION
Levels of Integrin ␤ 1 and DDR1 Determine Epithelial Cell Differentiation or Dedifferentiation
During development, the functions of integrin ␤ 1 and DDR1 in cell adhesion, migration, tubulogenesis, proliferation, and growth may be either cooperative or opposing. However, after maturation, the functions of integrin ␤ 1 and DDR1 in cell differentiation are consistently opposing. To delineate the function of integrin ␤ 1 and DDR1 in epithelial cells, cells can be grown on collagen-coated dishes. Grown on collagen, epithelial cells derived from mouse proximal tubule (MCT), Madin-Darby canine kidney (MDCK), mouse mammary gland (NMuMG), or porcine kidney (LLC-PK1) all gradually lose epithelial plasticity, as manifest by reduced microvilli, loss of E-cadherin-mediated cell-cell contacts, and gain of mesenchymal phenotypic changes, all characteristic of dedifferentiation (68, 86, 87) . As overexpression of DDR1 prevents collagenreduced microvilli formation and E-cadherin junctional localization (86) , and overexpression of constitutively active integrin ␤ 1 markedly reduces cell-cell association and triggers cell spreading and dedifferentiation (85), we conclude that integrin ␤ 1 and DDR1 confer the opposite effects in regulation of epithelial cell differentiation.
As E-cadherin-mediated adherens junctions play important roles in controlling epithelial cell differentiation, we further explored whether DDR1-triggered epithelial cell differentiation is mediated by regulation of E-cadherin. The results indicated that the turnover rate of E-cadherin was decreased by DDR1, whereas increased by knockdown of DDR1. Immunofluorescence analysis revealed that DDR1 expression decreased E-cadherin endocytosis, and live cell imaging revealed that DDR1 expression increased the membrane stability of E-cadherin (86) . On the other hand, in cells overexpressing constitutively active integrin ␤ 1 , E-cadherin staining was more pronounced in the cytosol than in the membrane (85) . The expression and activation of integrin ␤ 1 either reduces the membrane stability or decreases the expression level of Ecadherin, which leads to the dedifferentiation of epithelial cells (17, 34, 87) . As the intercellular and cell-ECM adhesion are the keys in maintaining cell tensegrity, the signals that imbalance the force generated by intercellular or cell-ECM adhesion would lead to the changes of cell mobility, invasion capability, cell differentiation, and the cell traction force (23, 56, 64) . From this point of view, the counteractive effects on Ecadherin stability explain the opposing actions of integrin ␤ 1 and DDR1 in epithelial cell differentiation.
Integrin ␤ 1 Downregulates E-Cadherin Stability
FAK, Src, and ILK are the major downstream protein kinases of integrin ␤ 1 . Increased activation and expression of FAK, Src, and ILK have been demonstrated in many cancerous and fibrotic tissues. Upon integrin engagement, FAK and Src are autophosphorylated and FAK phosphorylation at Y397 forms a strong binding site with activated Src. Consequently, the activated Src phosphorylates other tyrosine sites on FAK. The blocking of the FAK/Src signaling axis suppresses integrin ␤ 1 -induced E-cadherin endocytosis via stabilization of the membrane-bound E-cadherin, which switches collective cell migration to single-cell migration in squamous cell carcinoma cells (17) . Our previous study showed that Cdc42 is the downstream molecule involved in integrin ␤ 1 /FAK signaling axis-induced cell extension (84) , and reduction of Cdc42 activation decreases the endocytosis of E-cadherin in normal epithelial cells (86) . The actin cytoskeleton dynamics has been identified as the key in Cdc42-regulated E-cadherin membrane stability (33, 55) , which suggests that the Cdc42-regulated cytoskeleton organization is involved in integrin ␤ 1 -induced endocytosis of E-cadherin (Fig. 2) .
The increase in Src activation could lead to the disruption of E-cadherin-mediated cell-cell adhesion through the activation of integrin ␤ 1 and phosphorylation of FAK (7) . Further study showed that the signaling cascade, including integrin ␤ 1 , FAK, extracellular-regulated kinase (ERK), myosin light chain kinase (MLCK), and myosin light chain (MLC) is involved in the junctional localization of E-cadherin (5) . Interestingly, the increase in Cdc42 activation triggers the ubiquitination and endocytosis of E-cadherin through the augmentation of Src activation (30, 66) . Taken together, the bidirectional regulation of integrin ␤ 1 and Src, as well as Src and Cdc42, may contribute to integrin ␤ 1 -induced E-cadherin endocytosis and epithelial cell dedifferentiation (Fig. 2) .
ILK is a downstream effector of integrin ␤ 1 that mediates adherens junctions. Upregulation of ILK has been extensively studied in renal tubulointerstitial fibrosis. The in vitro experiments indicated that TGF-␤1 treatment increased the expression of ILK, and blocking of ILK suppressed TGF-␤1-induced EMT, including the downregulation of E-cadherin (58). Moreover, blocking of ILK suppressed UUO-induced chronic tubulointerstitial fibrosis (57) . Similar results have been observed after blocking the integrin ␤ 1 signal during UUO-induced renal fibrosis (85) . These results indicate that the integrin ␤ 1 /ILK signaling axis is required for TGF-␤1-induced EMT and UUOinduced renal tubulointerstitial fibrosis.
The effects of increased ILK expression have also been examined in highly invasive and poor prognostic cancers, such as ovarian (2), lung (70) , and colon (13) cancer. In the model of TGF-␤1-induced EMT, increased expression of ILK augmented protein stability and nuclear translocation of ␤-catenin via inhibition of GSK-3 phosphorylation. However, the ILKincreased ␤-catenin/T-cell factor transcriptional activity was not responsible for the downregulation of E-cadherin. Instead, increased expression of Snail, the transcriptional repressor of E-cadherin, mediates ILK-induced downregulation of E-cadherin (71) . Further study showed that the increase in Poly (ADP-ribose) polymerase-1 (PARP-1) transcriptional activation is required for ILK-induced Snail gene expression (Ref. 59 and Fig. 2 ). The regulatory mechanisms influencing integrin ␤ 1 -regulated adherens junctional stability may depend on the expression of downstream molecules and the coordination of microenvironmental cues.
DDR1 Upregulates E-Cadherin Stability
The mechanism whereby DDR1 increases E-cadherin membrane stability has been recently elucidated (86) . To assess , which provides contractile force and induces instability and endocytosis of E-cadherin. On the other hand, Src activation through growth factor signaling triggers the activation of integrin ␤1 and FAK which then induces the endocytosis of E-cadherin, suggesting the bidirectional regulation between integrin ␤1 and Src. Cdc42 and Rac1 activation is another downstream pathway of FAK/Src-induced instability of E-cadherin. The activation of Cdc42 and Rac1-mediated actin cytoskeleton reorganization is necessary for membrane stability and endocytosis of E-cadherin. Conversely, activation of Cdc42 positively regulates Src activation and Hakai-mediated endocytosis and degradation of E-cadherin. ILK, another downstream target of integrin ␤1, increases the transcriptional activity of Poly (ADP-ribose) polymerase-1 (PARP-1), which mediates downregulation of E-cadherin through the induction of the E-cadherin transcriptional repressor, Snail. The different downstream pathways are coordinated by microenvironmental cues. The counteractive function of DDR1 shows an increase in E-cadherin-mediated adherens junctions via inactivation of Cdc42. In summary, increased integrin ␤1 signaling induces the dedifferentiation of epithelial cells while increased DDR1 signaling promotes epithelial cell differentiation. In addition, activation of E-cadherin negatively regulates the gene expression of integrin ␤1 and the ligand-induced activation of DDR1 (top left), which indicates the negative regulation of adherens junctions on cell adhesions. membrane stability of E-cadherin, we employed mEosconjugated E-cadherin by taking advantage of mEos as a UV-sensitive photoconvertible fluorescent protein. Tracing of the movement of photo-converted or nonconverted mEos-Ecadherin provides a useful tool for evaluation of E-cadherin membrane stability. We found that the intensity of membrane photo-converted mEos-E-cadherin in DDR1-expressing cells sustained longer than that in DDR1 knockdown cells, suggesting that expression of DDR1 increases the membrane stability of E-cadherin. Expression of DDR1 increases the cortical actin structure, which is necessary for adherens junction stability, whereas knockdown of DDR1 increases stress fiber assembly, which impairs junctional stability. As DDR1 knockdown increases the activation level of Cdc42 and knockdown of Cdc42 rescues DDR1 knockdown-induced endocytosis of E-cadherin and cytoskeleton rearrangement, we conclude that DDR1 enhances adherens junctional stability via inactivation of Cdc42 (Ref. 86 and Fig. 2 ). Exactly how DDR1 regulates Cdc42 activation is not understood. The cytosolic domain of DDR1 is predicted to have a GTPase-activating protein (GAP)-binding element (25) . However, DDR1 regulation of Cdc42 activation through GAP has not been studied. On the other hand, as expression of DDR1 reduces focal adhesions in the cell periphery, we suggest that the expression of DDR1 may directly regulate the activation or expression of integrin ␤ 1 . Further studies will be needed to elucidate the mechanism whereby DDR1 regulates expression of integrin ␤1.
Activation of E-Cadherin Negatively Regulates Integrin ␤1 and DDR1
Regulation of intercellular and cell-ECM adhesions is complex. Expression of E-cadherin suppresses the expression of integrin ␣ 5 and ␤ 1 in MDA-MB-231 cells (81) , and in addition, the Ca 2ϩ -dependent E-cadherin dimerization suppresses focal adhesion formation and lamellipodia extension and dynamics (11, 82) . These results suggest that the E-cadherin-mediated adherens junction negatively regulates integrin ␤ 1 -mediated adhesion signal (Fig. 2) . In DDR1 knockdown cells, we found that the increased expression of E-cadherin reduces the expression of integrin ␤ 1 , and that the blocking of E-cadherin reverses the downregulation of integrin ␤ 1 promoter activity (unpublished observations), suggesting that E-cadherin-mediated adherens junction could provoke DDR1-regulated integrin ␤ 1 gene expression and cell differentiation.
Although DDR1 positively regulates E-cadherin membrane stability, activation of E-cadherin negatively regulates collagen-induced DDR1 phosphorylation. In various epithelial cells, DDR1 forms physical interactions with E-cadherin, independent of DDR1 or E-cadherin activation level. However, activation of E-cadherin suppressed collagen-induced DDR1 phosphorylation and limited cell spreading (78) . It is conceivable that stable cell-cell junctions in epithelial cells negatively regulate the activation of DDR1 by trapping DDR1 in the cell-cell junctions. Nevertheless, it is still not clear whether the physical interaction between DDR1 and E-cadherin is required for DDR1-regulated cell-cell adhesion.
CONCLUSION
The expression of two receptors for collagen in one cell is of particular interest because of the opposing cellular functions of these two collagen receptors. Loss of either integrin ␤ 1 or DDR1 leads to distinctly different developmental defects. Expression of integrin ␤ 1 is important in maintaining the basallateral cues for cell polarization, whereas expression of DDR1 triggers the formation of adherent junctions, a key step in epithelial cell differentiation. In disease progression, particularly in cancer progression and organ fibrosis, the counteractive functions of integrin ␤ 1 and DDR1 in regulating epithelial cell differentiation are especially notable: an increase in expression of integrin ␤ 1 is required for TGF-␤1-induced EMT and tubulointerstitial fibrosis, whereas overexpression of DDR1 suppresses TGF-␤1-induced EMT and maintains the integrity of tubular epithelial cells in the fibrotic kidney. Also, an increase in integrin ␤ 1 expression is usually seen in malignant tumors with less differentiation while an increase in DDR1 expression is observed in tumors that remain differentiated. The different functions of integrin ␤ 1 and DDR1 in regulating epithelial cell differentiation may be traced to different mechanisms in controlling the junctional stability of E-cadherin. Increase in integrin ␤ 1 expression disrupts E-cadherin-mediated cell-cell adhesion, whereas increase in DDR1 promotes junctional localization and membrane stability of E-cadherin. Interestingly, increases in both DDR1 and E-cadherin signals suppress expression of integrin ␤ 1 . Since integrin ␤ 1 and DDR1 play opposite roles in regulating epithelial cell differentiation, one might predict that DDR1 is downregulated in cancer cells. However, ample evidence indicates that DDR1 is overexpressed in various types of cancer. The pathological mechanisms underlying DDR1 overexpression in cancer remain to be investigated.
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